Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Science Advances|April 10, 2026
Innate immune sensing of dietary alcohol ignites inflammation to drive alcohol-related diseaseYeonseo Jang, Hoeun Bae, SuHyeon Oh, et al.
International Archives of Allergy and Immunology|March 12, 2026
Lanadelumab's Enduring Effectiveness and Safety in the Management of Hereditary Angioedema for Patients from Puerto Rico: Data from EMPOWERRafael H Zaragoza-Urdaz, Paula J Busse, Daniel Fox, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|October 29, 2014
Limitations in exercise and functional capacity in long-term postpneumonectomy patientsBaruch Vainshelboim, Benjamin Daniel Fox, Milton Saute, et al.
Frontiers in Cell and Developmental Biology|July 17, 2020
MicroRNA-223 Regulates Retinal Function and Inflammation in the Healthy and Degenerating RetinaNilisha Fernando, Josephine H C Wong, Shannon Das, et al.
The Journal of Allergy and Clinical Immunology. Global|June 22, 2026
Hereditary angioedema attack trends among patients maintained on lanadelumab long-term prophylaxisMaeve O'Connor, Joshua Jacobs, Laura Panattoni, et al.
MMWR. Morbidity and Mortality Weekly Report|September 13, 2019
Outbreak of Electronic-Cigarette-Associated Acute Lipoid Pneumonia - North Carolina, July-August 2019Kevin Davidson, Alison Brancato, Peter Heetderks, et al.
Allergy and Asthma Proceedings|March 17, 2026
Real-world quality of life in patients with hereditary angioedema receiving lanadelumab or other long-term prophylaxisMark Davis-Lorton, Daniel Soteres, William R Lumry, et al.
Science Immunology|May 20, 2022
Clostridium septicum α-toxin activates the NLRP3 inflammasome by engaging GPI-anchored proteinsWeidong Jing, Jordan Lo Pilato, Callum Kay, et al.
Immunology and Cell Biology|April 26, 2022
Mpeg1 is not essential for antibacterial or antiviral immunity, but is implicated in antigen presentationSalimeh Ebrahimnezhaddarzi, Catherina H Bird, Cody C Allison, et al.
International Archives of Allergy and Immunology|July 17, 2025
Long-Term Real-World Outcomes in Patients with Hereditary Angioedema Receiving Lanadelumab for 3 or More YearsWilliam R Lumry, Mark Davis-Lorton, Daniel Soteres, et al.
Pageof 13